S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ACH · Accendra Health, Inc.
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
Accendra Health Inc (ACH)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$0.22
-0.04
(-16.31%)
● At close: October 21 at 4:00:00 PM EDT
$0.22
+0.00
(+0.00%)
Overnight:
11:28:34 PM EDT
DAY'S RANGE
$0.22
$0.22
$0.25
52-WEEK RANGE
$0.22
$0.20
$5.60
What's happening
- ACH is down 16.31% today, trading at $0.22. — Live quote
- It's trading within 3% of its 52-week low ($0.20). (Finnhub fundamentals)
- Volume today (18,491) is well below its 3-month average of 1,409,590. (Finnhub fundamentals)
- Reports earnings on 2026-11-04 (before market open), 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.19 actual vs. $-0.09 estimated (-113.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 5
Sell 6
Strong sell 1
Aggregate ratings for 2026-10-01 (12 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ACH
-90.88%
vs S&P 500
-103.66%
1-YEAR RETURN
ACH
-94.83%
vs S&P 500
-109.39%
6-MONTH RETURN
ACH
-92.33%
3-MONTH RETURN
ACH
-92.53%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.19
Est. $-0.09
MISS -113.0%
2026-04-26 (Q1 2026)
$-0.04
Est. $-0.10
BEAT +60.9%
2026-01-26 (Q4 2025)
$0.21
Est. $0.22
MISS -5.8%
2025-10-26 (Q3 2025)
$0.25
Est. $0.23
BEAT +6.7%
Valuation Measures & Ratios
Enterprise Value4$1.73B
Forward P/E565.65
PEG Ratio6—
Price / Sales (TTM1)0.01
Price / Book71.22
EV4 / Revenue0.65
EV4 / EBITDA11.48
Profit Margin-11.41%
Operating Margin0.46%
Return on Equity (ROE8)-50.95%
Return on Assets (ROA9)-10.98%
Avg Volume (3M)1,409,590
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $32.9M | $22.9M | $46.4M | $87.5M | $88.2M |
| P/E | -0.03 | -0.02 | -0.04 | -0.09 | -0.96 |
| Price/Sales | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 |
| Price/Book | -0.06 | -0.05 | -0.11 | -0.31 | 0.15 |
| EV/Revenue | 0.01 | 0.10 | 0.11 | 0.16 | 0.02 |
| EV/EBITDA | 0.11 | 0.99 | 1.03 | — | — |
| ROE | 202.36% | 226.09% | 246.12% | 334.05% | -16.03% |
| ROA | -52.90% | -43.49% | -26.19% | -22.60% | -1.89% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short8,422,219
Change from Prior Settlement-5.32%
% of Float—
Days to Cover (Short Ratio)4.88
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-09; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -10.1% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -11.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -94.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ACH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $613.2M | $627.8M | $697.3M | $681.9M | $673.9M | $686.8M | $660.4M | $2.61B |
| Gross profit | — | — | — | — | $526.0M | $559.7M | $544.2M | $535.5M |
| Operating income | -$35.1M | $17.1M | $26.5M | -$39.7M | $19.8M | $31.1M | $16.9M | $9.7M |
| Net income | -$89.1M | -$6.5M | -$150.3M | -$869.1M | -$25.0M | -$12.8M | -$31.9M | -$21.9M |
| EPS (diluted) | $-1.16 | $-0.08 | $-1.94 | $-11.30 | $-0.32 | $-0.16 | $-0.42 | $-0.29 |
| EPS (basic) | $-1.16 | $-0.08 | $-1.94 | $-11.30 | $-0.32 | $-0.17 | $-0.42 | $-0.29 |
| Operating margin | -$6 | $3 | $4 | -$6 | $3 | $5 | $3 | $0 |
| Net margin | -$15 | -$1 | -$22 | -$127 | -$4 | -$2 | -$5 | -$1 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.11B | $2.42B | $2.45B | $4.04B | $4.15B | $4.86B | $4.66B | $5.08B |
| Total liabilities | $2.66B | $2.88B | $2.91B | $4.47B | $4.44B | $4.29B | $4.07B | $4.21B |
| Stockholders' equity | -$550.9M | -$464.8M | -$461.0M | -$429.5M | -$281.0M | $571.0M | $586.4M | $895.7M |
| Total current assets | $271.4M | $588.5M | $547.9M | $2.13B | $2.30B | $2.21B | $2.02B | $2.12B |
| Total current liabilities | $666.2M | $1.20B | $947.1M | $2.47B | $2.67B | $1.96B | $1.85B | $1.93B |
| Cash & equivalents | $7.7M | $336.9M | $282.0M | $32.8M | $38.3M | $59.4M | $27.6M | $45.5M |
| Inventory | $73.3M | $65.3M | $74.4M | $63.8M | $69.2M | $1.41B | $67.6M | $1.24B |
| Other current assets | $70.4M | $82.6M | $95.5M | $68.1M | $104.0M | $158.0M | $82.2M | $167.0M |
| Property, plant & equipment | $208.7M | $227.7M | $256.2M | $259.7M | $259.3M | — | $249.3M | — |
| Goodwill | $1.23B | $1.23B | $1.23B | $1.23B | $1.23B | $1.33B | $1.23B | $1.64B |
| Intangible assets | $78.0M | $107.2M | $136.5M | $165.7M | $194.9M | $285.1M | $210.1M | $313.3M |
| Other non-current assets | $224.1M | $162.4M | $174.0M | $131.9M | $53.5M | $129.8M | $89.5M | $153.3M |
| Accounts payable | $352.8M | $374.8M | $363.6M | $339.7M | $357.0M | $1.38B | $359.9M | $1.34B |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Short-term debt | $0 | $581.2M | $250.0M | $280.0M | $383.0M | $49.9M | $42.9M | $42.6M |
| Other current liabilities | $271.6M | $213.6M | $264.1M | $455.2M | $421.7M | $442.1M | $294.7M | $453.5M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $210.8M | $88.2M | $95.5M | $83.2M | $85.0M | $87.4M | $72.6M | $116.5M |
| Common stock & paid-in capital | $153.8M | $153.2M | $152.8M | $154.6M | $154.4M | $154.4M | $154.4M | $154.1M |
| Retained earnings | -$1.18B | -$1.09B | -$1.08B | -$1.02B | -$871.9M | $1.0M | $27.2M | $302.1M |
| Accumulated other comprehensive income (loss) | -$1.1M | -$798.0K | -$885.0K | -$30.4M | -$30.2M | -$44.2M | -$49.3M | -$27.4M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | -$172.5M | $37.6M | -$35.1M | $71.0M | $27.3M |
| Investing cash flow | -$31.2M | $53.9M | $285.0M | -$39.5M | -$52.9M | -$48.2M | -$52.3M | -$27.2M |
| Financing cash flow | -$272.0M | $51.1M | -$117.5M | $181.1M | $31.7M | $92.8M | -$43.1M | -$199.6M |
| Free cash flow | — | — | — | -$246.9M | -$20.0M | -$80.9M | $48.7M | -$30.3M |
| Capital expenditures | $47.6M | $41.6M | $13.1M | $74.4M | $57.6M | $45.8M | $22.3M | $57.7M |
| Depreciation & amortization | $65.7M | $61.7M | $29.9M | $98.8M | $43.0M | $42.9M | -$18.3M | $61.6M |
| Share-based compensation | $4.0M | $3.1M | -$4.5M | $8.0M | $4.9M | $4.4M | -$2.6M | $5.7M |
| Deferred income taxes | — | — | -$17.9M | — | — | — | -$8.0M | — |
| Change in inventory | $8.1M | -$9.2M | -$139.5M | $144.7M | -$4.7M | $6.3M | -$127.8M | $9.4M |
| Other investing activities | -$2.1M | $0 | $0 | $0 | $1.5M | $410.0K | -$7.0M | -$16.6M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | $0 | $3.5M | $0 | $5.2M | $1.5M | — | $0 |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | $1.24B | — | — | $0 | $0 | $0 | $32.8M | $199.1M |
| Other financing activities | -$187.0K | -$416.0K | -$44.6M | $41.7M | -$32.0K | -$146.0K | $7.2M | -$515.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $2.76B | $2.68B | $2.55B | $9.96B | $9.79B |
| Gross profit | — | $2.22B | $2.13B | $1.83B | $1.51B |
| Operating income | $27.5M | -$217.7M | $133.2M | $142.9M | $368.5M |
| Net income | -$1.10B | -$362.7M | -$41.3M | $22.4M | $221.6M |
| EPS (diluted) | $-14.31 | $-4.73 | $-0.53 | $0.29 | $2.94 |
| EPS (basic) | $-14.31 | $-4.73 | $-0.54 | $0.30 | $3.05 |
| Operating margin | $1 | -$8 | $5 | $1 | $4 |
| Net margin | -$40 | -$14 | -$2 | $0 | $2 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.45B | $4.66B | $5.09B | $5.39B | $3.54B |
| Total liabilities | $2.91B | $4.07B | $4.17B | $4.44B | $2.60B |
| Stockholders' equity | -$461.0M | $586.4M | $945.3M | $966.7M | $938.5M |
| Total current assets | $547.9M | $2.02B | $2.10B | $2.30B | $2.32B |
| Total current liabilities | $947.1M | $1.85B | $1.89B | $1.57B | $1.34B |
| Cash & equivalents | $282.0M | $27.6M | $243.0M | $69.5M | $55.7M |
| Inventory | $74.4M | $67.6M | $1.11B | $1.33B | $1.50B |
| Other current assets | $95.5M | $82.2M | $150.9M | $128.6M | $88.6M |
| Property, plant & equipment | $256.2M | $249.3M | — | — | — |
| Goodwill | $1.23B | $1.23B | $1.64B | $1.64B | $390.2M |
| Intangible assets | $136.5M | $210.1M | $361.8M | $445.0M | $209.7M |
| Other non-current assets | $174.0M | $89.5M | $149.3M | $150.4M | $103.6M |
| Accounts payable | $363.6M | $359.9M | $1.17B | $1.15B | $1.00B |
| Short-term debt | $250.0M | $42.9M | $206.9M | $17.9M | — |
| Other current liabilities | $264.1M | $294.7M | $396.7M | $307.9M | $226.2M |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $95.5M | $72.6M | $122.6M | $114.9M | $108.9M |
| Common stock & paid-in capital | $152.8M | $154.4M | $153.1M | $152.6M | $150.9M |
| Retained earnings | -$1.08B | $27.2M | $368.7M | $410.0M | $387.6M |
| Accumulated other comprehensive income (loss) | -$885.0K | -$49.3M | -$31.8M | -$35.9M | -$40.6M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | — | $161.5M | $740.7M | $325.0M | $124.2M |
| Investing cash flow | $144.4M | -$116.5M | -$137.3M | -$1.80B | -$53.6M |
| Financing cash flow | $188.1M | -$267.6M | -$417.3M | $1.50B | -$129.5M |
| Free cash flow | — | -$8.8M | $568.3M | $166.9M | $83.2M |
| Capital expenditures | $191.0M | $170.3M | $172.4M | $158.1M | $41.0M |
| Depreciation & amortization | $214.5M | $181.3M | $210.4M | $228.7M | $90.6M |
| Share-based compensation | $12.9M | $16.6M | $14.4M | $21.0M | $25.0M |
| Deferred income taxes | -$17.9M | -$8.0M | -$6.0M | -$26.4M | -$29.7M |
| Change in inventory | $6.9M | $4.6M | $5.4M | -$166.6M | $263.4M |
| Other investing activities | $1.9M | -$14.7M | $936.0K | $1.7M | $3.9M |
| Dividends paid | — | — | $0 | $0 | $731.0K |
| Share repurchases | $10.2M | — | — | — | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | $244.2M | $320.7M | $4.5M | $553.1M |
| Other financing activities | -$3.1M | -$5.8M | $5.6M | -$42.8M | -$18.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ACH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-05-15 to 2026-10-05
Recent transactions
- Most recent: Gardner-Smith Kenneth (President & CEO) — Grant / award of 283,554 shares on 2026-10-05.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Gardner-Smith Kenneth | President & CEO | Grant / award | 2026-10-05 | 283,554 |
| Leon Jonathan A | EVP & CFO | Tax withholding | 2026-09-23 | 4,265 |
| Galloway Heath H | EVP,General Counsel & CorpSecy | Tax withholding | 2026-05-18 | 1,822 |
| Pesicka Edward A | President & CEO | Tax withholding | 2026-05-15 | 17,692 |
| Bernocchi Perry A | EVP, Chief Operating Officer | Tax withholding | 2026-05-15 | 7,908 |
| Kline Teresa L. | Director | Grant / award | 2026-05-14 | 31,191 |
| Klemash Stephen W | Director | Grant / award | 2026-05-14 | 31,191 |
| Beck Mark A | Director | Grant / award | 2026-05-14 | 31,191 |
| Long Andrew G | EVP, CEO P&HS | Gift | 2025-11-19 | 47,908 |
| Coliseum Capital Management, LLC | Reporting person | Open market purchase | 2025-08-14 | 492,852 |
| Stone Jennifer A | EVP, CHRO | Tax withholding | 2025-06-03 | 5,764 |
| Rollins Carissa | Director | Grant / award | 2025-05-15 | 28,914 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Gardner-Smith Kenneth | President & CEO | Grant / award | 283,554 | $0.00 |
| 2026-09-23 | Leon Jonathan A | EVP & CFO | Tax withholding | 4,265 | $0.85 |
| 2026-05-18 | Galloway Heath H | EVP,General Counsel & CorpSecy | Tax withholding | 1,822 | $2.91 |
| 2026-05-15 | Leon Jonathan A | EVP & CFO | Tax withholding | 1,770 | $3.04 |
| 2026-05-15 | Pesicka Edward A | President & CEO | Tax withholding | 17,692 | $3.04 |
| 2026-05-15 | Galloway Heath H | EVP,General Counsel & CorpSecy | Tax withholding | 966 | $3.04 |
| 2026-05-15 | Bernocchi Perry A | EVP, Chief Operating Officer | Tax withholding | 7,908 | $3.04 |
| 2026-05-14 | Kline Teresa L. | Director | Grant / award | 31,191 | $0.00 |
| 2026-05-14 | Klemash Stephen W | Director | Grant / award | 31,191 | $0.00 |
| 2026-05-14 | Gardner-Smith Kenneth | Director | Grant / award | 31,191 | $0.00 |
| 2026-05-14 | Beck Mark A | Director | Grant / award | 31,191 | $0.00 |
| 2026-03-20 | Pesicka Edward A | President & CEO | Tax withholding | 58,945 | $2.03 |
| 2026-03-20 | Leon Jonathan A | EVP & CFO | Tax withholding | 11,286 | $2.03 |
| 2026-03-20 | Bernocchi Perry A | EVP, Chief Operating Officer | Tax withholding | 20,841 | $2.03 |
| 2026-03-20 | Galloway Heath H | EVP,General Counsel & CorpSecy | Tax withholding | 9,347 | $2.03 |
| 2026-03-09 | Bernocchi Perry A | EVP, Chief Operating Officer | Grant / award | 108,696 | $0.00 |
| 2026-03-09 | Leon Jonathan A | EVP & CFO | Grant / award | 85,067 | $0.00 |
| 2026-03-09 | Galloway Heath H | EVP,General Counsel & CorpSecy | Grant / award | 61,437 | $0.00 |
| 2025-11-19 | Long Andrew G | EVP, CEO P&HS | Gift | 47,908 | $0.00 |
| 2025-09-23 | Leon Jonathan A | EVP & CFO | Tax withholding | 4,265 | $5.40 |
| 2025-08-14 | Coliseum Capital Management, LLC | Reporting person | Open market purchase | 492,852 | $5.31 |
| 2025-08-13 | Coliseum Capital Management, LLC | Reporting person | Open market purchase | 325,000 | $5.46 |
| 2025-08-12 | Coliseum Capital Management, LLC | Reporting person | Open market purchase | 720,000 | $5.15 |
| 2025-06-03 | Stone Jennifer A | EVP, CHRO | Tax withholding | 5,764 | $6.35 |
| 2025-05-19 | Galloway Heath H | EVP,General Counsel & CorpSecy | Tax withholding | 1,768 | $7.38 |
| 2025-05-15 | Rollins Carissa | Director | Grant / award | 28,914 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 03:33 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-09 | 8-K | 2026-10-06 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-23 | View on SEC.gov → |
| 2026-09-17 | 8-K | 2026-09-16 | View on SEC.gov → |
| 2026-08-17 | 8-K | 2026-08-17 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-09 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-06-25 | 8-K | 2026-06-23 | View on SEC.gov → |
| 2026-06-15 | 8-K | 2026-06-09 | View on SEC.gov → |
| 2026-05-22 | 8-K | 2026-05-22 | View on SEC.gov → |
Recent news
Headlines about ACH (Accendra Health, Inc.). Links open the publisher — we don’t host full articles.
-
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 2026-10-21 -
Accendra Health appoints Gardner-Smith before Accendra Health stock update
AD HOC NEWS · 2026-10-20 -
Same Day ACH Growth Propels the ACH Network Forward in Third Quarter of 2026
Yahoo Finance · 2026-10-20 -
Lauriana Ach - Say Who - le média des communautés influentes de notre époque
saywhomedia.com · 2026-10-19 -
ACH PRE 14A & SEC Filings
Yahoo Finance · 2026-10-19 -
Analysts set USD 1.50 target for Accendra Health stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-17 -
Postmarket Movers for Oct. 16, 2026: BitFuFu, Zone Frontier Among Gainers; ATA Creativity, Zhibao Among Losers
ChartMill · 2026-10-16 -
What 39 percent ACH growth means for Usio stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-15
No headlines in this category right now — try “All”.